Skip to main content
Translational Andrology and Urology logoLink to Translational Andrology and Urology
. 2026 Jul 9;15(7):257. doi: 10.21037/tau-20262-03

Erratum: Enzalutamide-resistant related lncRNA NONHSAT210528 promotes the proliferation and invasion of prostate cancer

Editorial Office1
PMCID: PMC13458613  PMID: 42583043

In the article entitled “Enzalutamide-resistant related lncRNA NONHSAT210528 promotes the proliferation and invasion of prostate cancer” (1), three pairs of images across Figure 7F and Figure 7H, selected to represent transwell assays that detected the invasion of C4-2 and C4-2b cells, were erroneously arranged.

Figure 7F and 7H of the original article:

graphic file with name tau-15-07-257-fig1.jpg

The correct version of Figure 7 is shown below.

graphic file with name tau-15-07-257-fig2.jpg

The authors regretted the error and confirmed that this error did not significantly affect either the results or the conclusions of the paper.

Click here to view the updated version of the article.

Supplementary

The article’s supplementary files as

DOI: 10.21037/tau-20262-03

References

  • 1.Ye C, Chen YG, Qin SF, et al. Enzalutamide-resistant related lncRNA NONHSAT210528 promotes the proliferation and invasion of prostate cancer. Transl Androl Urol 2022;11:643-58. 10.21037/tau-22-99 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

The article’s supplementary files as

DOI: 10.21037/tau-20262-03

Articles from Translational Andrology and Urology are provided here courtesy of AME Publications

RESOURCES